Skip to content

CHECKED

Companies Insolvencies Sectors Watchlist Alerts API

Swiftpharma

Genk ·KBO/BCE: BE 0781.598.284

Loading dossier…

Checked · Insight, alerts and connections for every Belgian company, from official sources.

NL FR EN

Product

Search companies Sectors Radar Live Compare Prospects Supplier check Feasibility

Data & registers

Insolvencies Curators Directors Director bans Protection orders Notaries News

Account

Watchlist Portfolio Alerts Pricing

Checked

About Methodology Knowledge base Sources FAQ Help API Badge

Legal

Privacy Terms Contact

Checked AI

Open a company dossier to ask Checked AI about it.

Answers from Checked AI. Not legal advice.

Metric	This company	Sector median	Position in the sector
Solvency	17.0%	35.1%	better than 29% of 319 sector peers
Net result	€-1.75M	€44k	better than 5% of 319 sector peers
Equity	€835k	€272k	better than 72% of 319 sector peers
Gross operating margin	€-22k	€237k	better than 7% of 318 sector peers
Staff costs	€1.19M	€171k	higher than 93% of 200 sector peers

Fiscal year	2025
Revenue	-
EBITDA	€-1.23M
Net profit	€-1.75M
Cash flow	€-1.31M
Staff costs	€1.19M
Income taxes	€998
Dividends	-
Total assets	€4.90M
Equity	€835k
Debt	€4.06M
of which ≤ 1y	€543k
of which > 1y	€3.52M
Working capital	€175k
Employees (FTE)	12.3

	2025
Current ratio	1.32
Quick ratio	1.32
Working capital ratio	3.6%
Solvency	17.0%
Debt / equity	4.87
Long-term debt ratio	4.22
Interest coverage	-14.13
Gross margin	-
Net margin	-
ROA	-35.7%
ROE	-209.7%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€4.90M
Fixed assets	21/28	€4.18M
Intangible fixed assets	21	€2.02M
Tangible fixed assets	22/27	€2.13M
Financial fixed assets	28	€30k
Current assets	29/58	€718k
Amounts receivable within one year	40/41	€255k
Cash & bank	54/58	€434k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€4.90M
Equity	10/15	€835k
Contributions / capital	10/11	€4.41M
Reserves	13	€57k
Accumulated profits (losses)	14	€-3.63M
Amounts payable	17/49	€4.06M
Amounts payable after one year	17	€3.52M
Amounts payable within one year	42/48	€543k
Trade debts payable within one year	44	€372k
Income statement
Gross operating margin	9900	€-22k
Operating result	9901	€-1.67M
Financial income	75	€4k
Financial charges	65	€87k
Result before taxes	9903	€-1.75M
Income taxes	67/77	€998
Net result for the period	9904	€-1.75M
Result to be appropriated	9905	€-1.75M

NACE primary	Groothandel in farmaceutische en medische artikelen(46460)
Legal form	Private limited company(610)
Incorporation	04-02-2022
Status	Active
Postal code	3600

Swiftpharma

Swiftpharma

Summary

Conclusion

Bankruptcy probability (12 mo)

Trust signals

Administrative Flags

Financials

Annual accounts & ratios

Health barometer

Directors

Directors & mandates

Insolvency mandates

Legal Structure

Structure & network

Locations & real estate

Registered office

Establishment units

Real-estate footprint

Analysis

Snowflake analysis

Ask AI about this company

AI due-diligence brief

Credit advice

Similar

Similar companies

Company registry

Company registry (CBE)